Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC

X Niu, L Chen, Y Li, Z Hu, F He - Seminars in Cancer Biology, 2022 - Elsevier
Small cell lung cancer (SCLC) is an aggressive form of lung cancer characterized by dismal
prognosis. Although SCLC may initially respond well to platinum-based chemotherapy, it …

Therapeutic implications of tumor microenvironment in lung cancer: focus on immune checkpoint blockade

C Genova, C Dellepiane, P Carrega… - Frontiers in …, 2022 - frontiersin.org
In the last decade, the treatment of non-small cell lung cancer (NSCLC) has been
revolutionized by the introduction of immune checkpoint inhibitors (ICI) directed against …

GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels

CJ Liu, FF Hu, GY Xie, YR Miao, XW Li… - Briefings in …, 2023 - academic.oup.com
Cancer initiation and progression are likely caused by the dysregulation of biological
pathways. Gene set analysis (GSA) could improve the signal-to-noise ratio and identify …

Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion

X Sun, B Wu, HC Chiang, H Deng, X Zhang, W Xiong… - Nature, 2021 - nature.com
Immune exclusion predicts poor patient outcomes in multiple malignancies, including triple-
negative breast cancer (TNBC). The extracellular matrix (ECM) contributes to immune …

GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA

C Li, Z Tang, W Zhang, Z Ye, F Liu - Nucleic Acids Research, 2021 - academic.oup.com
In 2017, we released GEPIA (Gene Expression Profiling Interactive Analysis) webserver to
facilitate the widely used analyses based on the bulk gene expression datasets in the TCGA …

IOBR: multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures

D Zeng, Z Ye, R Shen, G Yu, J Wu, Y Xiong… - Frontiers in …, 2021 - frontiersin.org
Recent advances in next-generation sequencing (NGS) technologies have triggered the
rapid accumulation of publicly available multi-omics datasets. The application of integrated …

Germline variants associated with toxicity to immune checkpoint blockade

S Groha, SA Alaiwi, W Xu, V Naranbhai, AH Nassar… - Nature medicine, 2022 - nature.com
Immune checkpoint inhibitors (ICIs) have yielded remarkable responses but often lead to
immune-related adverse events (irAEs). Although germline causes for irAEs have been …

[HTML][HTML] Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer

J Hu, A Yu, B Othmane, D Qiu, H Li, C Li, P Liu… - Theranostics, 2021 - ncbi.nlm.nih.gov
Rationale: Siglec15 is an emerging target for normalization cancer immunotherapy.
However, pan-cancer anti-Siglec15 treatment is not yet validated and the potential role of …

[HTML][HTML] CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance

C Wang, Y Li, L Jia, J koo Kim, J Li, P Deng, W Zhang… - Cell stem cell, 2021 - cell.com
Immunosurveillance is a critical mechanism guarding against tumor development and
progression. Checkpoint inhibitors have shown significant success in cancer treatment, but …

Crosstalk between 5-methylcytosine and N6-methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in …

Y Tian, H Xiao, Y Yang, P Zhang, J Yuan, W Zhang… - Molecular cancer, 2023 - Springer
Background Accumulated evidence highlights the significance of the crosstalk between
epigenetic and epitranscriptomic mechanisms, notably 5-methylcytosine (5mC) and N6 …